Bristol Myers Squibb was hot commodity during ASCO and while remains at historically high prices, this stock is trading sideways around the $46-47 range as investors wonder whether they were intoxicated by all the hype around the BMS pipeline.
Bristol Myers Squibb was hot commodity during ASCO and while remains at historically high prices, this stock is trading sideways around the $46-47 range as investors wonder whether they were intoxicated by all the hype around the BMS pipeline.